Top Markets
Coin of the day
Anteris Technologies Global Corp. Anteris Technologies Global Corp.

Anteris Technologies Global Corp.

AVR
Rang in aandelen #10272
Anteris Technologies Global Corp. is a structural heart innovator dedicated to... Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Aandeelprijs
$8.88
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$863.29M
Verandering (1 dag)
-1.02%
Verandering (1 jaar)
120.86%
Land
US
Handel Anteris Technologies Global Corp. (AVR)

Categorie

Koersgeschiedenis voor Anteris Technologies Global Corp. (AVR)
Hoogste slotkoers: $9.07 op 2026-08-01

Laagste slotkoers: $5.59 op 2024-12-01
Koersgeschiedenis van Anteris Technologies Global Corp. van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 28.26%
2025 -11.64%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$112.64 -15.09%
US
$331.44 -15.32%
US
$91.30 -1.63%
IE
$46.83 -55.61%
US
$46.88 -15.20%
DE